Davita Inc vs Fortuna Mining Corp. Common Shares — how do they compare? Davita Inc trades at $179.25 (market cap $11.29B), while Fortuna Mining Corp. Common Shares trades at $10.92 (market cap $3.13B). The key difference: Davita Inc is far larger — about 3.6× Fortuna Mining Corp. Common Shares's market cap, and Davita Inc is more actively traded (582,204 versus 6,504,680). Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and Fortuna Mining Corp. Common Shares for 1 Days on average.
| DVA | FSM | |
|---|---|---|
Market Cap | $11.29B | $3.13B |
Volume | 582,204 | 6,504,680 |
Sector | Health | Basic Materials |
52-Week High | $240.96 | $13.66 |
52-Week Low | $103.87 | $7.84 |
Typical Hold Time | 114 Days | 1 Days |
Enterprise Value | $24.01B | $2.75B |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, up 0.14% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 15 and revenue growth from $13.64B in 2025 to projected $14.0B in 2026. Recent news highlights value-based care expansion with Humana and institutional buying by BlackRock. Technical indicators show resistance at $179 and support at $175, with RSI neutral at 59.72.
DVA presents a mixed outlook: analyst consensus targets $235.67 (33% upside) with 43% buy ratings, but technicals suggest near-term pressure. Key opportunities include consistent EPS beats and partnership growth, while risks involve rising debt-to-asset ratio (65.55% in 2025) and regulatory exposure. Net cash flow turned negative in 2025, requiring monitoring.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Fortuna Mining is a Canadian precious-metals mining company with operations in Latin America and West Africa. It produces gold and silver and conducts exploration activities in several countries.
Read more on FSM →